Showing results (31-40 of 98) with videos related to
Sort By:
Pageof 10
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|February 12, 2014
The effects of denosumab on calcium profiles in advanced cancer patients with bone metastasesBreanne Lechner, Carlo DeAngelis, Noreen Jamal, et al.Journal of Bone Oncology|February 25, 2016
Skeletal morbidity rates over time in patients with bone metastases from solid tumors reported in bone modifying agents randomised trialsMichael Poon, Liang Zeng, Liying Zhang, et al.Journal of Comparative Effectiveness Research|November 19, 2013
Adverse events across generations of bone-modifying agents in patients with solid tumor cancers reported in Phase III randomized trialsMichael Poon, Liying Zhang, Florence Mok, et al.Clinical Genitourinary Cancer|March 9, 2024
Mainstream Model of Genetic Testing for Prostate Cancer at a Large Tertiary Cancer CentreXin Wang, Larissa Waldman, Yael Silberman, et al.Urologic Oncology|October 22, 2022
UnCHAARTED territory: The role of docetaxel rechallenge following chemohormonal therapy for metastatic castration-sensitive prostate cancerMary Mahler, Esmail Al-Ezzi, Noa Shani Shrem, et al.BMJ Open|November 9, 2022
Prostate MRI versus PSA screening for prostate cancer detection (the MVP Study): a randomised clinical trialRobert Nam, Chirag Patel, Laurent Milot, et al.Cancer Research|August 17, 2005
Low-dose metronomic combined with intermittent bolus-dose cyclophosphamide is an effective long-term chemotherapy treatment strategyYuval Shaked, Urban Emmenegger, Giulio Francia, et al.Journal of Geriatric Oncology|March 29, 2023
Impact of treatment on elder-relevant physical function and quality of life outcomes in older adults with metastatic castration-resistant prostate cancerHelen Yang, Valerie S Kim, Narhari Timilshina, et al.Plos One|November 19, 2024
Correction: The impact of sarcopenia on clinical outcomes in men with metastatic castrate-resistant prostate cancerEfthymios Papadopoulos, Andy Kin On Wong, Sharon Hiu Ching Law, et al.Molecular Cancer Therapeutics|October 18, 2005
Down-regulation of DNA mismatch repair proteins in human and murine tumor spheroids: implications for multicellular resistance to alkylating agentsGiulio Francia, Shane K Green, Guido Bocci, et al.Pageof 10